Results 141 to 150 of about 25,923,262 (305)

Do the selected Trans European transport investments pass the Cost Benefit test? [PDF]

open access: yes
This paper assesses the economic justification for the selection of priority projects defined under the auspices of the Trans-European transport network.
Artem KORZHENEVYCH   +5 more
core  

VALUE OF UNIVERSAL CHILDHOOD VARICELLA VACCINATION IN SLOVENIA

open access: yesZdravniški Vestnik, 2002
Background. In 1974 effective and safe vaccine against varicella was developed. Vaccination is recomended for universal childhood immunisation in some of west European countries and in the United States.
Jerneja Ahčan   +3 more
doaj  

The Development of Rheumatoid Arthritis–Specific Ambulatory Care–Sensitive Conditions: Results of a Consensus Process

open access: yesArthritis Care &Research, EarlyView.
Objective Ambulatory care–sensitive conditions (ACSCs) serve as indicators of access, quality, and performance of the health system. This study aimed to determine rheumatoid arthritis (RA)‐specific ACSCs for use in the evaluation of care system access and quality.
Kara Irwin   +7 more
wiley   +1 more source

COST-BENEFIT ANALYSIS – A HELPFUL INSTRUMENT FOR THE ABSORPTION VALUATION OF STRUCTURAL AND COHESION FUNDS IN ROMANIA [PDF]

open access: yes
Starting with the entering in European Union, absorption of structural and cohesion funds seemed to be a challenge for Romania. But unfortunately, after the first half of the programming period, cost-benefit analysis of projects from different ...
Ecaterina Mariana SUCIU   +3 more
core  

Beyond Visual Scoring: Computational Computed Tomography Analysis for High‐Resolution Computed Tomography–Based Quantification of Interstitial Lung Disease in Inflammatory Rheumatic Disease

open access: yesArthritis Care &Research, EarlyView.
Interstitial lung disease (ILD) is a significant cause of morbidity and mortality in patients with inflammatory rheumatic disorders (IRDs). High‐resolution computed tomography (HRCT) is widely considered the gold standard for the noninvasive assessment of ILD; however, its interpretation is constrained by substantial interobserver variability and the ...
Alexander Pfeil   +7 more
wiley   +1 more source

Cost-Benefit Analysis in a Framework of Stakeholder Involvement and Integrated Coastal Zone Modeling [PDF]

open access: yes
Active involvement of local stakeholders is currently an increasingly important requirement in European environmental regulations such as the EU Water Framework Directive (WFD) and the EU Marine Strategy Framework Directive (MSFD).
Söderqvist, Tore   +4 more
core  

Facial Cosmetic Therapy Use Among Patients With Systemic Sclerosis: An Australian Cohort Study

open access: yesArthritis Care &Research, EarlyView.
Objective Systemic sclerosis (SSc) is associated with numerous facial manifestations for which patients may engage in cosmetic therapies. It is unclear how patients with SSc use these therapies. This study sought to characterize patient engagement and experiences with cosmetic therapies for SSc‐related and non‐SSc–related facial changes.
Zachary Warren   +11 more
wiley   +1 more source

Cost-benefit analysis for alcohol strategy.

open access: yes, 2012
A cost-benefit analysis will have to be undertaken before the implementation of radical measures recommended in order to tackle alcohol abuse, including the introduction of a levy and banning of alcohol sponsorship of major cultural events, Irish Medical
Mudiwa, Lloyd
core  

Validation of Patient‐Reported Outcomes Measurement Information System (PROMIS) Pediatric Measures for Children With Chronic Nonbacterial Osteomyelitis

open access: yesArthritis Care &Research, EarlyView.
Objective To assess the validity of the Patient‐Reported Outcomes Measurement Information System (PROMIS) Pediatric measures in patients with chronic nonbacterial osteomyelitis (CNO). Methods Within the longitudinal patient registry of CNO, English‐speaking patients aged 8 years and older self‐reported PROMIS Pediatric measures of fatigue, pain ...
Mary M. Eckert   +43 more
wiley   +1 more source

Home - About - Disclaimer - Privacy